Screener
Amphastar Pharmaceuticals AMPH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Income tax refunds, deposits, and payable, net | 14,847 | (8,467) |
| Operating lease liabilities | (3,616) | (2,362) |
| Accounts payable and accrued liabilities | 11,563 | 12,747 |
| Net cash provided by operating activities | 99,164 | 70,669 |
| Cash Flows From Investing Activities: | ||
| Purchases and construction of property, plant, and equipment | (18,098) | (21,262) |
| Purchase of intangible assets | — | (2,250) |
| Purchase of investments | (31,790) | (15,619) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's operating cash flow?
- Amphastar Pharmaceuticals (AMPH) reported operating cash flow of $51.32M in Q2 2026.
- How has Amphastar Pharmaceuticals's operating cash flow changed year-over-year?
- Amphastar Pharmaceuticals's operating cash flow increased by 44.2% year-over-year, from $35.59M to $51.32M.
- What is the long-term trend for Amphastar Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's operating cash flow has grown at a 12.3% compound annual growth rate (CAGR), from $97.99M to $156.12M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Amphastar Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude